Patients who are Jehovah’s Witnesses are known to the medical community for frequently declining blood products, even at times of life-threatening anemia. Alternatives to red blood cell transfusion are being developed, including hemoglobin (Hb)-based oxygen carriers. We present the case of a 77-year-old male Jehovah’s Witness who underwent a cystoprostatectomy and radical nephrectomy with a postoperative Hb nadir of 4.5 g/dL. He received an Hb-based oxygen carrier, PEGylated carboxyhemoglobin bovine (Sanguinate), with gradual improvement in anemia symptoms and eventual discharge to a short-term rehabilitation facility.
From the Department of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Accepted for publication August 21, 2018
The authors declare no conflicts of interest.
Address correspondence to Stephen McHugh, MD, University of Pittsburgh Department of Anesthesiology, 5230 Centre Ave, Pittsburgh, PA 15232. Address e-mail to email@example.com.